Your search returned 462 results.

Results
	441.	In vitro activity of ceftaroline-avibactam against gram-negative and gram-positive pathogens isolated from patients in Canadian hospitals from 2010 to 2012: results from the CANWARD surveillance study. [electronic resource] by Karlowsky, James A Adam, Heather J Baxter, Melanie R Lagacé-Wiens, Philippe R S Walkty, Andrew J Hoban, Daryl J Zhanel, George G Producer: 20140514 In: Antimicrobial agents and chemotherapy vol. 57 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	442.	Ceftaroline fosamil for the treatment of hospital-acquired pneumonia and ventilator-associated pneumonia. [electronic resource] by Kaye, Keith S Udeani, George Cole, Phillip Friedland, Hillel David Producer: 20160314 In: Hospital practice (1995) vol. 43 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	443.	Supporting the ceftaroline fosamil/avibactam Enterobacteriaceae breakpoint determination using humanised in vivo exposures in a thigh model. [electronic resource] by Bhalodi, Amira A Crandon, Jared L Williams, Gregory Nicolau, David P Producer: 20170412 In: International journal of antimicrobial agents vol. 44 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	444.	CANVAS 1 and 2: analysis of clinical response at day 3 in two phase 3 trials of ceftaroline fosamil versus vancomycin plus aztreonam in treatment of acute bacterial skin and skin structure infections. [electronic resource] by Friedland, H David O'Neal, Tanya Biek, Donald Eckburg, Paul B Rank, Douglas R Llorens, Lily Smith, Alex Witherell, Gary W Laudano, Joseph B Thye, Dirk Producer: 20120817 In: Antimicrobial agents and chemotherapy vol. 56 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	445.	A series of pharmacokinetic studies of ceftaroline fosamil in select populations: normal subjects, healthy elderly subjects, and subjects with renal impairment or end-stage renal disease requiring hemodialysis. [electronic resource] by Riccobene, Todd Jakate, Abhijeet Rank, Doug Producer: 20150129 In: Journal of clinical pharmacology vol. 54 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	446.	In vivo efficacy of humanized ceftaroline fosamil-avibactam exposures in a polymicrobial infection model. [electronic resource] by Bhalodi, Amira A Crandon, Jared L Williams, Gregory Nicolau, David P Producer: 20140514 In: Antimicrobial agents and chemotherapy vol. 57 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	447.	Cerebrospinal fluid pharmacokinetics of ceftaroline in neurosurgical patients with an external ventricular drain. [electronic resource] by Chauzy, Alexia Nadji, Abdelouaid Combes, Jean-Christophe Defrance, Nadine Bouhemad, Belaid Couet, William Chavanet, Pascal Producer: 20200603 In: The Journal of antimicrobial chemotherapy vol. 74 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	448.	Ceftaroline modulates the innate immune and host defense responses of immunocompetent cells exposed to cigarette smoke. [electronic resource] by Bruno, A Cipollina, C Di Vincenzo, S Siena, L Dino, P Di Gaudio, F Gjomarkaj, M Pace, E Producer: 20170905 In: Toxicology letters vol. 279 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	449.	Ceftaroline Activity Against Multidrug-Resistant Streptococcus pneumoniae from U.S. Medical Centers (2014) and Molecular Characterization of a Single Ceftaroline Nonsusceptible Isolate. [electronic resource] by Pfaller, Michael A Mendes, Rodrigo E Flamm, Robert K Jones, Ronald N Sader, Helio S Producer: 20180330 In: Microbial drug resistance (Larchmont, N.Y.) vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	450.	Evaluation of the Presence and Characterization of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Level Resistance Among Bloodstream Isolates of Methicillin-Resistant [electronic resource] by Ozmen Capin, Busra Betul Tekeli, Alper Karahan, Zeynep Ceren Producer: 20201207 In: Microbial drug resistance (Larchmont, N.Y.) vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	451.	Ceftaroline increases membrane binding and enhances the activity of daptomycin against daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus in a pharmacokinetic/pharmacodynamic model. [electronic resource] by Werth, Brian J Sakoulas, George Rose, Warren E Pogliano, Joseph Tewhey, Ryan Rybak, Michael J Producer: 20130610 In: Antimicrobial agents and chemotherapy vol. 57 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	452.	Ceftaroline-Resistant, Daptomycin-Tolerant, and Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus Causing Infective Endocarditis. [electronic resource] by Nigo, Masayuki Diaz, Lorena Carvajal, Lina P Tran, Truc T Rios, Rafael Panesso, Diana Garavito, Juan D Miller, William R Wanger, Audrey Weinstock, George Munita, Jose M Arias, Cesar A Chambers, Henry F Producer: 20170920 In: Antimicrobial agents and chemotherapy vol. 61 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	453.	Ceftaroline fosamil therapy in patients with acute bacterial skin and skin-structure infections with systemic inflammatory signs: A retrospective dose comparison across three pivotal trials. [electronic resource] by Corey, G Ralph Wilcox, Mark H Gonzalez, Jesus Jandourek, Alena Wilson, David J Friedland, H David Das, Shampa Iaconis, Joseph Dryden, Matthew Producer: 20190902 In: International journal of antimicrobial agents vol. 53 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	454.	Ceftaroline fosamil for treatment of diabetic foot infections: the CAPTURE study experience. [electronic resource] by Lipsky, Benjamin A Cannon, Chad M Ramani, Ananthakrishnan Jandourek, Alena Calmaggi, Anibal Friedland, H D Goldstein, Ellie J C Producer: 20160113 In: Diabetes/metabolism research and reviews vol. 31 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	455.	PBP2a mutations causing high-level Ceftaroline resistance in clinical methicillin-resistant Staphylococcus aureus isolates. [electronic resource] by Long, S Wesley Olsen, Randall J Mehta, Shrenik C Palzkill, Timothy Cernoch, Patricia L Perez, Katherine K Musick, William L Rosato, Adriana E Musser, James M Producer: 20150803 In: Antimicrobial agents and chemotherapy vol. 58 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	456.	New Approaches to Antibiotic Use and Review of Recently Approved Antimicrobial Agents. [electronic resource] by Hahn, Andrew W Jain, Rupali Spach, David H Producer: 20170206 In: The Medical clinics of North America vol. 100 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	457.	Ceftaroline Activity Tested Against Bacterial Isolates Causing Community-acquired Respiratory Tract Infections and Skin and Skin Structure Infections in Pediatric Patients From United States Hospitals: 2012-2014. [electronic resource] by Pfaller, Michael A Mendes, Rodrigo E Castanheira, Mariana Flamm, Robert K Jones, Ronald N Sader, Helio S Producer: 20170420 In: The Pediatric infectious disease journal vol. 36 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	458.	Characterization of methicillin-resistant Staphylococcus aureus displaying increased MICs of ceftaroline. [electronic resource] by Mendes, Rodrigo E Tsakris, Athanassios Sader, Helio S Jones, Ronald N Biek, Donald McGhee, Pamela Appelbaum, Peter C Kosowska-Shick, Klaudia Producer: 20120724 In: The Journal of antimicrobial chemotherapy vol. 67 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	459.	A Phase III, randomized, controlled, non-inferiority trial of ceftaroline fosamil 600 mg every 8 h versus vancomycin plus aztreonam in patients with complicated skin and soft tissue infection with systemic inflammatory response or underlying comorbidities. [electronic resource] by Dryden, Matthew Zhang, Yingyuan Wilson, David Iaconis, Joseph P Gonzalez, Jesus Producer: 20170814 In: The Journal of antimicrobial chemotherapy vol. 71 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	460.	Macrolide therapy for community-acquired pneumonia due to atypical pathogens: outcome assessment at an early time point. [electronic resource] by File, Thomas M Eckburg, Paul B Talbot, George H Llorens, Lily Friedland, H David Producer: 20180501 In: International journal of antimicrobial agents vol. 50 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search

Availability

Authors

Topics

Languages

Your search returned 462 results.